Cholesterol-lowering statins possess anti-inflammatory activity that might be useful for treatment of MS Cholesterol-lowering statins possess anti-inflammatory activity that might be useful for treatment of MS2018-01-17T17:05:43-05:00
Protective and therapeutic role for aB-crystallin in autoimmune demyelination Protective and therapeutic role for aB-crystallin in autoimmune demyelination2018-01-17T17:05:43-05:00
Involvement of both ‘allergic’ and ‘autoimmune’ mechanisms in EAE, MS and other autoimmune diseases Involvement of both ‘allergic’ and ‘autoimmune’ mechanisms in EAE, MS and other autoimmune diseases2018-01-17T17:05:23-05:00
Design of effective immunotherapy for human autoimmunity Design of effective immunotherapy for human autoimmunity2018-01-17T17:03:46-05:00
Design of effective immunotherapy for human autoimmunity Design of effective immunotherapy for human autoimmunity2018-01-17T17:03:46-05:00
How to Successfully Apply Animal Studies in Experimental Allergic Encephalomyelitis to Research on Multiple Sclerosis How to Successfully Apply Animal Studies in Experimental Allergic Encephalomyelitis to Research on Multiple Sclerosis2018-01-17T17:03:18-05:00
Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells2018-01-17T17:01:35-05:00
Therapeutic Considerations for Disease Progression in Multiple Sclerosis Therapeutic Considerations for Disease Progression in Multiple Sclerosis2018-01-17T17:01:30-05:00
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis2018-01-17T17:00:56-05:00
What went wrong in the natalizumab trials? What went wrong in the natalizumab trials?2018-01-17T16:59:56-05:00
